The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

acolytebiomedica.com

Founded Year

2000

Stage

Acquired | Acquired

Total Raised

$13.46M

About Acolyte

Provider of diagnostic systems for clinical microbiology. The company provides systems based on the bioluminescent detection of adenylate kinase, designed to enable the microbial detection and antibiotic sensitivity determination in hours instead of days, thereby reducing costs and hospital-acquired infections. [Keywords: methicillin-resistant staphylococcus aureus (MRSA)]

Acolyte Headquarter Location

Building 227

Salisbury, SP4 0JQ,

United Kingdom

44 1980 551320

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.